Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2023
Companies covered: 10
Tables & Figures: 301
Countries covered: 19
Pages: 171
Download Free PDF
Upstream Bioprocessing Market
Get a free sample of this report
Get a free sample of this report Upstream Bioprocessing Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Upstream Bioprocessing Market Size
Upstream Bioprocessing Market size was valued at USD 9.5 billion in 2023 and is anticipated to grow at CAGR of 9.7% from 2024 and 2032. One of the major factors contributing to the growth is the increasing demand for biopharmaceuticals caused by high prevalence of chronic diseases.
Therefore, the efficient and scalable upstream processes are essential to meet the growing demand for biopharmaceuticals & advanced therapies and address unmet medical needs. Further, the technological advancements such as single-use bioreactors, high-throughput screening, and bioreactor design, enhance productivity, efficiency, and scalability contributes to the increasing adoption of upstream bioprocessing.
Upstream bioprocessing refers to the initial stages of biotechnological production processes involved in manufacturing biological products such as pharmaceuticals, enzymes, or biofuels. It encompasses various steps from the selection and cultivation of host organisms (such as bacteria, yeast, or mammalian cells) to the preparation of the growth medium and the actual cultivation of these organisms in bioreactors or fermenters.